China Universal Asset Management Company’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$115K Buy
2025
Q1
$60.8K Buy
2024
Q4
$54.9K Buy
2024
Q3
$42.4K Buy
2024
Q2
$15.2K Sell
2024
Q1
$36.9K Buy
2023
Q4
$115K Buy
2023
Q3
$31.7K Buy
2023
Q2
$19K Sell
2023
Q1
$26.3K Buy
2022
Q4
$24.9K Buy